Patent intelligence · US
US 9526882
Percutaneous administration device and method for producing the same
Percutaneous administration device and method for producing the same
Patent details — US 9526882
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 27, 2016
- Expiration
- Dec 22, 2036
- Applicant
- OPTNICS PRECISION CO., LTD.
- Claims
- 8
- CPC classes
- A61K, A61K2800/87, A61K8/676, A61K9/703
Quick answer
US 9526882 (Percutaneous administration device and method for producing the same) is held by OPTNICS PRECISION CO., LTD.. Status: granted. Granted Dec 27, 2016. Expires Dec 22, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- OPTNICS PRECISION CO., LTD.
- Grant date
- Expiration
- Claims
- 8
- CPC classes
- A61K, A61K2800/87, A61K8/676, A61K9/703, A61K9/7084, A61K9/7092
More from OPTNICS PRECISION CO., LTD.
Related pharmaceutical patents in our USPTO index.
-
US 12419920
Bifidobacterium longum NCIMB 41676
granted -
US 12410418
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 12351839
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
granted -
US 12344676
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 12336835
Neuromodulation to target glucose transporter and/or incretin pathways
granted -
US 12232492
Disinfection of bacteriophages products using supercritical carbon dioxide
granted -
US 12233135
Therapeutic constructs for treating cancer
granted -
US 12180463
Lactobacillus reuteri
granted
Frequently asked questions
What is US patent 9526882?
US 9526882 (Percutaneous administration device and method for producing the same) is held by OPTNICS PRECISION CO., LTD.. Status: granted. Granted Dec 27, 2016. Expires Dec 22, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9526882?
OPTNICS PRECISION CO., LTD. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 158 pharmaceutical patents for this assignee.
When does US 9526882 expire?
Our index shows an expiration date of Dec 22, 2036 (10 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.